58.91
+3.35
+(6.03%)
At close: 1:44:04 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 11 | 11 |
| Avg. Estimate | 20.76B | 21.01B | 84.64B | 88.35B |
| Low Estimate | 20.41B | 20.76B | 83.86B | 86.39B |
| High Estimate | 21.23B | 21.31B | 86.14B | 90.67B |
| Year Ago Sales | 20.86B | 20.69B | 82.3B | 84.64B |
| Sales Growth (year/est) | -0.50% | 1.54% | 2.85% | 4.37% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NWT.F | -- | -- | -- | -- |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Upgrade | Piper Sandler: Neutral to Overweight | 4/8/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 4/7/2025 |
| Maintains | Truist Securities: Buy to Buy | 4/4/2025 |
| Maintains | JP Morgan: Neutral to Neutral | 4/3/2025 |
| Maintains | B of A Securities: Buy to Buy | 4/2/2025 |
| Maintains | Citigroup: Neutral to Neutral | 3/24/2025 |